GLEEVEC (IMATINIB): A BREAKTHROUGH IN CANCER TREATMENT

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2016, Vol 5, Issue 6

Abstract

Deregulated protein tyrosine kinase activity is central to the pathogenesis of human cancers. Targeted therapy in the form of selective tyrosine kinase inhibitors (TKIs) has transformed the approach to management of various cancers and represents a therapeutic breakthrough. Imatinib was one of the first cancer therapies to show the potential for such targeted action. Imatinib, an oral targeted therapy, inhibits tyrosine kinases specifically BCR-ABL, c-KIT, and PDGFRA. Apart from its remarkable success in CML and GIST, Imatinib benefits various other tumors caused by Imatinib-specific abnormalities of PDGFR and c-KIT. Imatinib has also been proven to be effective in steroid-refractory chronic graft-versus-host disease because of its anti-PDGFR action. Gleevec has been approved for the treatment of patients with positive inoperable and/or metastatic malignant gastrointestinal stromal tumors (GISTs). Gleevec is a signal transduction inhibitor that works by targeting the activity of enzymes called tyrosine kinases. The activity of one of these tyrosine kinases, known as c-kit, is thought to drive the growth and division of most GISTs. Key words: CML, GIST, PDGFRA

Authors and Affiliations

Sakshi Minocha

Keywords

Related Articles

Incidence of depression in type 2 diabetes mellitus patients with or without complications

Diabetes Mellitus refers to a group of common metabolic disorder associated with abnormalities in carbohydrate, fat and protein metabolism and results in chronic complications including microvascular, macrovascular and n...

Immunopharmacological activity of medicinal plants against Aristolochia bracteolate and Phallus impudicus

Introduction: Immunological attempt was made to determine the potential of sevenimportant medicinally plants viz., Ficus benghalensis, Mangifera indica, Adhatoda vasica, Syzygium cumini, Terminalia arjuna, Ficus religios...

Optimization and validation of RP-HPLC method for the estimation of chlorzoxazone and paracetamol with its genotoxic impurity (4-amino phenol) in bulk and pharmaceutical drug product using PDA detector

A simple, accurate, precise, reproducible RP-HPLC method has been developed for simultaneous estimation of chlorzoxazone (CZX) and paracetamol (PCM) with its genotoxic impurity, p-amino phenol (4-AP) in bulk and combined...

ESTIMATION OF THE INCIDENCE OF INTRAOPERATIVE AWARENESS AND RECALL IN WAD MEDANI TEACHING HOSPITAL - SUDAN

The study was having been conducted in Wad Medani Teaching Hospital from March to September 2016. The objective of the study was to estimate the incidence of awareness under general anesthesia in Wad Medani Teaching Hosp...

Prescribing Pattern of Antibiotics in Intensive Care Unit of a Tertiary Care Teaching Hospital

Antibiotics are the most commonly administered drugs in ICU. By optimizing the use of antibiotics within ICU, patient outcomes are improved, better initial antibiotics administration is provided, and the chance of furthe...

Download PDF file
  • EP ID EP418080
  • DOI -
  • Views 108
  • Downloads 0

How To Cite

Sakshi Minocha (2016). GLEEVEC (IMATINIB): A BREAKTHROUGH IN CANCER TREATMENT. Journal of Biomedical and Pharmaceutical Research, 5(6), 137-152. https://europub.co.uk/articles/-A-418080